A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.

ABSTRACT:

SUBMITTER: Zeidner JF 

PROVIDER: S-EPMC8557202 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature